84
Participants
Start Date
December 15, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Neoadjuvant Chemotherapy
Participants will receive standard of care neoadjuvant chemotherapy
Radiation Therapy
Radiotherapy simulation parameters will be at the discretion of the treating physician to account for the patient's body habitus, tumor bed location, and tolerability of the prone or supine positions, however, the recommended approach will be whole-breast RT (WBRT) in the prone position, for cT1-3 N0 patients who achieve ecCR. For cT1-2 N1 patients who achieve ecCR WBRT with nodal inclusion and lymph node boost will be performed in the supine position.
MRI
Participants will undergo MRI
Breast Cancer Surgery
Participants will undergo surgery to treat their breast cancer. Either a lumpectomy or a mastectomy will be performed.
Biopsy
Participants undergo biopsy
Biospecimen collection
Participants undergo blood and plasma collection
Ohio State University Comprehensive Cancer Center, Columbus
Gateway for Cancer Research
OTHER
Ohio State University Comprehensive Cancer Center
OTHER